Correction to “Microglial Melatonin Receptor 1 Degrades Pathological Alpha-Synuclein Through Activating LC3-Associated Phagocytosis In Vitro”

IF 4.8 1区医学 Q1 NEUROSCIENCES

CNS Neuroscience & Therapeutics Pub Date : 2025-01-13 DOI:10.1111/cns.70219

引用次数: 0

Abstract

Yao XY, Cao BE, Liu JY, Lv QK, Zhang JR, Cheng XY, Mao CJ, Ma QH, Wang F, Liu CF. “Microglial Melatonin Receptor 1 Degrades Pathological Alpha-Synuclein Through Activating LC3-Associated Phagocytosis In Vitro”. CNS Neurosci Ther. 2024;30(10):e70088. doi: 10.1111/cns.70088.

The authors would like to correct Figure 2B, as errors were made during its preparation for publication. We declare that these corrections do not alter the results or conclusions of this paper. The corrected version of Figure 2, including Figure 2B, is provided here.

Abstract Image

查看原文本刊更多论文

更正“小胶质褪黑素受体1通过激活lc3相关的体外吞噬作用降解病理性α -突触核蛋白”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CNS Neuroscience & Therapeutics 医学-神经科学

CiteScore

7.30

自引率

12.70%

发文量

240

审稿时长

2 months

期刊介绍： CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.